These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 11931345)

  • 1. Drug design at peptide receptors: somatostatin receptor ligands.
    Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
    J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features.
    Siehler S; Zupanc GK; Seuwen K; Hoyer D
    Neuropharmacology; 1999 Mar; 38(3):449-62. PubMed ID: 10219983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
    Siehler S; Seuwen K; Hoyer D
    Eur J Pharmacol; 1998 May; 348(2-3):311-20. PubMed ID: 9652348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation of human cerebral cortex somatostatin SRIF1 and SRIF2 receptors.
    Piwko C; Thoss VS; Schüpbach E; Kummer J; Langenegger D; Probst A; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):161-7. PubMed ID: 9050007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):510-21. PubMed ID: 10598790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgammaS binding.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):500-9. PubMed ID: 10598789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-pyridylthioureas: novel nonpeptide somatostatin agonists with SST4 selectivity.
    Liu S; Crider AM; Tang C; Ho B; Ankersen M; Stidsen CE
    Curr Pharm Des; 1999 Apr; 5(4):255-63. PubMed ID: 10101224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery.
    Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D
    J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain.
    Videau C; Hochgeschwender U; Kreienkamp HJ; Brennan MB; Viollet C; Richter D; Epelbaum J
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):562-71. PubMed ID: 12759718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
    Thoss VS; Piwko C; Probst A; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptors in the rhesus monkey brain: localization and pharmacological characterization.
    Thoss VS; Piwko C; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):648-60. PubMed ID: 8738298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.
    Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD
    Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies.
    Siehler S; Seuwen K; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):488-99. PubMed ID: 10598788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs.
    Cervia D; Fehlmann D; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):578-87. PubMed ID: 12750875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
    Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
    Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806.
    Nunn C; Schoeffter P; Langenegger D; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):1-9. PubMed ID: 12616335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity.
    Siehler S; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):522-32. PubMed ID: 10598791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.
    Bruns C; Lewis I; Briner U; Meno-Tetang G; Weckbecker G
    Eur J Endocrinol; 2002 May; 146(5):707-16. PubMed ID: 11980628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA.
    Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP
    J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.